UBS downgrades Merck to Neutral from Buy
UBS downgrades MRK to Neutral from Buy, changing its view on the stock; no catalyst was supplied in the alert.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.